Suvanza Pharma, LLC
Not enough financial coverage to compute a composite score for SUVZ. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.suvanza.com
Suvanza Pharma, LLC operates as an early-stage biotechnology corporation and engages in the development of the skin drug delivery system, RapiDerm for dermatologic diseases. Suvanza Pharma, LLC was formerly known as Hamilton PNG and changed its name to Suvanza Pharma, LLC in March 2010. The company was founded in 2004 and is based in Miami Beach, Florida.
- CEO
- Nardo Zaias
- IPO
- 1995
- HQ
- Miami Beach, FL, US
Price Chart
Performance & Tape
- 52W High
- $0.05
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.55
- Avg Volume
- 3
Get TickerSpark's AI analysis on SUVZ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SUVZ Coverage
We haven't published any research on SUVZ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SUVZ Report →